TCG International Biotech Park houses a diverse community of researchers collaborating to create transformative innovation to bring positive change in the biotech industry. Our occupants encompass leaders essentially in biotech and pharmaceutical solutions. They share a profound commitment to driving positive change within the life sciences sector, continuously challenging the boundaries of possibility.

This blog post introduces some of the remarkable occupants of our Biotech Park. We hope that by the end of this article, you’ll gain a better understanding of the exciting endeavours flourishing within our premises, and perhaps even find inspiration to join us in our mission to bring about meaningful change.

Meet Our Occupants

• Emcure: Emcure’s core strength and competitive edge stem from its well-established presence in key therapeutic domains, such as gynaecology, cardiology, blood-related conditions, oncology, respiratory ailments, CNS disorders, and HIV, among others. The company has successfully introduced six biosimilars into both the Domestic Market and RoW markets. Notably, Emcure holds a prominent position as a domestic leader in three biologics. Emcure dedicates itself to R&D and community health, expanding into biosimilars to provide accessible alternatives to biologic drugs and enhance medication accessibility.
• Gennova Biopharmaceuticals: Gennova is a brand that is committed to the development, production, and commercialisation of biotherapeutics to combat life-threatening diseases across diverse medical areas, and is revolutionising healthcare. The company is pioneering the creation of streamlined and efficacious manufacturing solutions while achieving successful commercialisation of bio-therapeutics in segments such as cardiovascular, neurology, nephrology, and oncology. This is accomplished through the integration of recombinant DNA technologies and cutting-edge bio-manufacturing practices.
• Seqens: Seqens has risen to prominence as a worldwide leader in delivering customised pharmaceutical solutions that cover the entire spectrum of drug substance development and manufacturing. Their comprehensive range of services includes the production of Active Pharmaceutical Ingredients (APIs) and specialty ingredients, catering to a wide array of industries, including healthcare, electronics, cosmetics and food. In essence, Seqens is dedicated to offering tailored solutions that meet the unique needs of its clients in various sectors, ensuring high-quality products across the board.
• Centaur
• Hikal: Hikal, as a prominent player in the life sciences sector, extends its expertise and services across the entire value chain. The company is renowned for delivering high-quality active ingredients, intermediates, and comprehensive research and development (R&D) solutions. These offerings cater to a diverse clientele, including leading global pharmaceutical companies, animal health organisations, biotechnology firms, crop protection enterprises, and specialty chemicals manufacturers. 
• Innovassynth: Innovassynth serves as a trusted Custom Development & Manufacturing Organisation for various global industries, including Pharma &diagnostics, organometallics, petrochemical & polymers, flavours & fragrance, and specialty chemicals. With over two decades of expertise, they are recognised as a versatile nucleosides & specialty chemicals company. Their customer-centric approach focuses on process optimisation, scale-up, adherence to high-quality and safety standards, and delivering cost-effective solutions to global customers.
• OmniActive: OmniActive Health Technologies serves as a global nutraceutical ingredient supplier, driven by innovative research and quality assurance. Their products are relied upon by leading brands in food, beverages, dietary supplements, and personal care.
• TCG Lifesciences (Chembiotech): TCG Lifesciences Pvt. Ltd. stands as a global frontrunner in innovative R&D services. Concentrating on areas like inflammation, infectious diseases, central nervous systems, and oncology, they collaborate with pharmaceutical and biotech firms worldwide to address unmet medical needs.
• MJ Biopharma: The MJ Group, a growing multinational conglomerate, has established its footprint across a spectrum of industries including pharmaceuticals, biotechnology, flavours, fragrances, agro chemicals, and specialty chemicals. Over the course of the last three decades, this dynamic organisation has demonstrated consistent growth in each of these sectors by delivering top-quality products that contribute to the improvement of human life.
• Deepak Novochem: Deepak Novochem Technologies LTD. thrives on innovative value addition. They synthesise various chemicals, including phenols and specialty amines, emphasising green chemistry, alternate technologies, and niche markets. Their ambition is to become a pivotal partner in the global chemical and life sciences landscape.

Conclusion

In conclusion, TCG International Biotech Park, with its unwavering commitment to fostering innovation and collaboration in the biotech and life sciences arena, offers a promising future for those who aspire to make a significant impact on the world. It serves as a beacon for innovators and researchers, providing them with a nurturing environment to turn their ideas into groundbreaking solutions that can shape the future of biotech and beyond. If you share the passion for driving positive change in the areas of biotech and life sciences, TCG-IBP warmly invites you to join this thriving community of visionaries and contribute to the transformative innovations that are reshaping the industry.